FDA records indicate that there are no current recalls for this drug.
Are you a medical professional?
Trending Topics
Micort-hc Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
There is currently no warning information available for this product. We apologize for any inconvenience.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
History
There is currently no drug history available for this drug.
Other Information
The topical corticosteroids constitute a class of primarily synthetic steroids used as anti-inflammatory and anti-pruritic agents. Hydrocortisone acetate is a member of this class. Hydrocortisone acetate has a molecular formula of C23H32O6, and its molecular weight of 404.50. The CAS registry number is 50-03-3. The chemical name is Pregn-4-ene-3,20-dione,21-(acetyloxy)-11,17-dihydroxy-, (11P)- and the chemical structural formula is presented below:
C23H32O6
MiCort-HC Lipocream 2% is a topical preparation containing hydrocortisone acetate 2% w/w in a water washable cream containing the following inactive ingredients: cetostearyl alcohol, ceteth 20, light mineral oil, white petrolatum, propylparaben, butylparaben, citric acid, sodium citrate, and purified water.
Sources
Micort-hc Manufacturers
-
Ferndale Laboratories, Inc.
Micort-hc | Ferndale Laboratories, Inc.
Topical corticosteroids are generally applied to the affected areas as a thin film two to four times daily depending on the severity of the condition.
Occlusive dressing may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the used of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.
Login To Your Free Account